Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.30
+1.39 (6.07%)
At close: Jun 26, 2026, 4:00 PM EDT
24.50
+0.20 (0.82%)
After-hours: Jun 26, 2026, 7:51 PM EDT
Castle Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Castle Biosciences stock have an average target of 42.43, with a low estimate of 35 and a high estimate of 52. The average target predicts an increase of 74.61% from the current stock price of 24.30.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Castle Biosciences stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 9 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Initiates $40 | Buy | Initiates | $40 | +64.61% | Jun 24, 2026 |
| KeyBanc | KeyBanc | Buy Maintains $50 → $35 | Buy | Maintains | $50 → $35 | +44.03% | May 29, 2026 |
| BTIG | BTIG | Buy Reiterates $50 → $40 | Buy | Reiterates | $50 → $40 | +64.61% | May 13, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $44 → $43 | Buy | Maintains | $44 → $43 | +76.95% | May 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $40 | Buy | Maintains | $40 | +64.61% | May 7, 2026 |
Financial Forecast
Revenue This Year
352.69M
from 344.23M
Increased by 2.46%
Revenue Next Year
393.47M
from 352.69M
Increased by 11.56%
EPS This Year
-1.40
from -0.83
EPS Next Year
-0.93
from -1.40
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 355.0M | 405.5M | |
| Avg | 352.7M | 393.5M | |
| Low | 350.2M | 384.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.1% | 15.0% | |
| Avg | 2.5% | 11.6% | |
| Low | 1.7% | 9.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.84 | -0.37 | |
| Avg | -1.40 | -0.93 | |
| Low | -1.74 | -1.67 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.